Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development

Nosavanh L., Yu DH., Jaehnig EJ., Tong Q., Shen L., Chen MH.

Animal Study, published in Proc Natl Acad Sci U S A (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Proc Natl Acad Sci U S A (2015)
Reported sample size
—
Source database
Europe PMC
PMID
25848030
PMCID
PMC4413261
DOI
10.1073/pnas.1420978112
Citations
40

Abstract (original English)

Although recent studies have shown that brown adipose tissue (BAT) arises from progenitor cells that also give rise to skeletal muscle, the developmental signals that control the formation of BAT remain largely unknown. Here, we show that brown preadipocytes possess primary cilia and can respond to Hedgehog (Hh) signaling. Furthermore, cell-autonomous activation of Hh signaling blocks early brown-preadipocyte differentiation, inhibits BAT formation in vivo, and results in replacement of neck BAT with poorly differentiated skeletal muscle. Finally, we show that Hh signaling inhibits BAT formation partially through up-regulation of chicken ovalbumin upstream promoter transcription factor II (COUP-TFII). Taken together, our studies uncover a previously unidentified role for Hh as an inhibitor of BAT development.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CiliaAnimalsMiceSignal TransductionCell DifferentiationUp-RegulationCOUP Transcription Factor IIAdipose Tissue, BrownHedgehog ProteinsAdipocytes, Brown

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.